Yukio NAKAMURA, Takako SUZUKI, Hideshi YAMAZAKI, and Hiroyuki KATO, “Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis”, Archives of Rheumatology, vol. 33, no. 2, pp. 154–159, Jun. 2018.